LPI (LP Information)' newest research report, the ﾓGlycobiology Industry Forecastﾔ looks at past sales and reviews total world Glycobiology sales in 2022, providing a comprehensive analysis by region and market sector of projected Glycobiology sales for 2023 through 2029. With Glycobiology sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Glycobiology industry. This Insight Report provides a comprehensive analysis of the global Glycobiology landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Glycobiology portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firmsﾒ unique position in an accelerating global Glycobiology market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Glycobiology and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Glycobiology. The global Glycobiology market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029. United States market for Glycobiology is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029. China market for Glycobiology is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029. Europe market for Glycobiology is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029. Global key Glycobiology players cover Agilent Technologies, Bruker Corp, Waters Corp, Thermo Fisher Scientific, Takara Bio, Merck, Shimadzu Corp, Prozyme and New England Biolabs, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022. This report presents a comprehensive overview, market shares, and growth opportunities of Glycobiology market by product type, application, key players and key regions and countries. Market Segmentation: Segmentation by type Reagents Instruments Kits Enzymes Segmentation by application Drug Discovery and Development Immunology Diagnostics Oncology Others This report also splits the market by region: Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration. Agilent Technologies Bruker Corp Waters Corp Thermo Fisher Scientific Takara Bio Merck Shimadzu Corp Prozyme New England Biolabs Danaher Corp
1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Glycobiology Market Size 2018-2029 2.1.2 Glycobiolo
